Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board approved unaudited standalone and consolidated financial results for Q2 FY26 and H1 FY26 (ended 30 September 2025). Standalone revenue rose to Rs. 24,837 lakhs (vs Rs. 22,880 lakhs in Q2 FY25), with H1 revenue at Rs. 48,578 lakhs. Profit before tax jumped sharply to Rs. 120 lakhs in Q2 (vs Rs. 87 lakhs) and Rs. 207 lakhs for H1 (vs Rs. 93 lakhs), while H1 profit after tax more than doubled to Rs. 155 lakhs. Consolidated H1 PAT stood at Rs. 273 lakhs (vs Rs. 14 lakhs). The Board declared an interim dividend of Rs. 0.20 per share (10% on face value of Rs. 2), with record date 10 November 2025. Independent Director and Audit Committee Chairman Mr. Purushottam Agarwal will step down on 30 November 2025, and Mr. Vedant Kanoi will take over as Audit Committee Chairperson. ESOPs were granted to employees at Rs. 14.20 per share (40% discount on Rs. 23.67 closing price), and M/s G R A M AND ASSOCIATES LLP was appointed as Internal Auditor for FY26.
Strong profit growth in H1 FY26 with a 10% interim dividend is a positive signal for shareholders, though dividend outflow of about Rs. 63.91 lakhs is small relative to scale. The director transition and ESOP grant at a discounted price may have minor governance and dilution implications to watch.